Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Oncoimmunology|November 18, 2016
Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responsesViswa Teja Colluru, Christopher D Zahm, Douglas G McNeelPharmacology & Therapeutics|February 11, 2017
DNA vaccines for prostate cancerChristopher D Zahm, Viswa Teja Colluru, Douglas G McNeelOncotarget|September 24, 2016
B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccinesViswa Teja Colluru, Douglas G McNeelCancer Immunology Research|June 22, 2017
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T CellsChristopher D Zahm, Viswa T Colluru, Douglas G McNeelOncoimmunology|May 17, 2021
PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacyChristopher D Zahm, Jena E Moseman, Lauren E Delmastro, et al.Cancer Immunology Research|September 12, 2018
TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8Christopher D Zahm, Viswa T Colluru, Sean J McIlwain, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 20, 2007
Cellular immunotherapies for prostate cancerDouglas G McNeelJournal for Immunotherapy of Cancer|November 24, 2016
TCR diversity - a universal cancer immunotherapy biomarker?Douglas G McNeelBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 30, 2017
Therapeutic Cancer Vaccines: How Much Closer Are We?Douglas G McNeelPageof 14